quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:30:00·77d
PRRelease
Intelligent Bio Solutions Inc. logo

Intelligent Bio Solutions Expects to Report Fiscal Second Quarter 2026 Revenue Growth of Approximately 48% Year-Over-Year, Surpassing $2 Million in Total Revenue for First Half of Fiscal Year

INBS· Intelligent Bio Solutions Inc.
Health Care
Original source

Companies

  • INBS
    Intelligent Bio Solutions Inc.
    Health Care

Related

  • SEC3d
    Intelligent Bio Solutions Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
  • PR6d
    Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified
  • PR21d
    Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market
  • PR28d
    Intelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant
  • SEC31d
    Intelligent Bio Solutions Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits
  • SEC31d
    SEC Form 424B5 filed by Intelligent Bio Solutions Inc.
  • INSIDER34d
    SEC Form 4 filed by Boyages Steven Constantine
  • INSIDER34d
    SEC Form 4 filed by Hurd Jonathan Scott
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022